On Nov. 12, 2020, CureVac announced that its mRNA-based COVID-19 vaccine candidate, CVnCoV, remained stable and within defined specifications for at least three months when stored at a standard refrigerator temperature of +5ﾰC (+41ﾰF) and up to 24 hours as ready-to-use vaccine when stored at room temperature.